COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants
COVIDOCRECHE
Contamination and Transmission of the SARS-CoV-2 Virus in Exposed, Confined and Community-based Infants: A Cross-sectional, Multicentre, Interventional Seroprevalence Study
2 other identifiers
interventional
600
1 country
11
Brief Summary
According to epidemiological models, the seroprevalence of SARS-CoV-2 infection in Île-de-France as of 11 May was between 10 and 15%. Preliminary data on the number of professionals evicted from nurseries on suspicion of COVID-19 (on clinical grounds) seem to be of the same order of magnitude, but need to be confirmed by a biological technique. Children would be susceptible to infection but often asymptomatic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2020
Shorter than P25 for not_applicable
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2020
CompletedStudy Start
First participant enrolled
June 2, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 2, 2020
CompletedOctober 26, 2020
May 1, 2020
1 month
June 2, 2020
October 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assess the serological status/rate of past infections in the children of priority staff in the nursery during the containment period
Proportion of children with a positive rapid serological test (presence of anti-SARS-CoV2 antibodies (IgM or IgG)).
Day of intervention (1 day)
Study Arms (1)
Interventional
EXPERIMENTALnasopharyngeal and blood sample
Interventions
Rapid serological test by taking 3 drops of blood from the fingertip via the TDR device (rapid detection test) for children, supervising nursery staff and hospital laboratory and administrative staff
Eligibility Criteria
You may qualify if:
- Population 1 :
- Consent of the holders of parental authority
- Affiliated to a social security system or entitled person
- Population 2 :
- Consent to participate
- Affiliated to a social security system or entitled person
- Population 3 :
- Hospital staff not exposed to patients and/or children, with or without children in day care, working in the bacteriology, biochemistry and biological haematology laboratories or in an administrative department of the participating hospitals.
- Affiliated to a social security system or entitled person
You may not qualify if:
- Population 1 :
- Refusal to sign consent by parents
- Clinical condition requiring urgent medical assessment (attending physician or transfer to paediatric emergency)
- Population 2 and 3 :
- Refusal to sign consent for staff
- Clinical condition requiring urgent medical evaluation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
Hopital Avicenne
Bobigny, 93000, France
Hôpital Jean Verdier - Service de Pédiatrie
Bondy, 93143, France
Hôpital Jean Verdier
Bondy, 93143, France
Hôpital Antoine béclère
Clamart, 92140, France
Hôpital Louis Mourier
Colombes, 92700, France
CH intercommunal de Créteil
Créteil, 94000, France
Hôpital Annecy Genevois
Épagny, France
Hôpital Andé Mignot
Le Chesnay, 78150, France
Hôpital Trousseau
Paris, 75012, France
Hôpital Robert debré
Paris, 75019, France
CHU de Rouen
Rouen, 76000, France
Related Publications (1)
Lachassinne E, de Pontual L, Caseris M, Lorrot M, Guilluy C, Naud A, Dommergues MA, Pinquier D, Wannepain E, Hausherr E, Jung C, Gajdos V, Cohen R, Zahar JR, Brichler S, Basmaci R, Boelle PY, Bloch-Queyrat C, Aupiais C; COVIDOCRECHE collaborators. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study. Lancet Child Adolesc Health. 2021 Apr;5(4):256-264. doi: 10.1016/S2352-4642(21)00024-9. Epub 2021 Feb 8.
PMID: 33571450DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric LACHASSINNE, MD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2020
First Posted
June 4, 2020
Study Start
June 2, 2020
Primary Completion
July 2, 2020
Study Completion
October 2, 2020
Last Updated
October 26, 2020
Record last verified: 2020-05